Cite
Mineralocorticoid Receptor Antagonists for Nephroprotection: Current Evidence and Future Perspectives
MLA
Pantelis Sarafidis, et al. “Mineralocorticoid Receptor Antagonists for Nephroprotection: Current Evidence and Future Perspectives.” Current Pharmaceutical Design, vol. 24, Apr. 2019, pp. 5528–36. EBSCOhost, https://doi.org/10.2174/1381612825666190306162658.
APA
Pantelis Sarafidis, Evangelos Memmos, Aikaterini Papagianni, & Maria-Eleni Alexandrou. (2019). Mineralocorticoid Receptor Antagonists for Nephroprotection: Current Evidence and Future Perspectives. Current Pharmaceutical Design, 24, 5528–5536. https://doi.org/10.2174/1381612825666190306162658
Chicago
Pantelis Sarafidis, Evangelos Memmos, Aikaterini Papagianni, and Maria-Eleni Alexandrou. 2019. “Mineralocorticoid Receptor Antagonists for Nephroprotection: Current Evidence and Future Perspectives.” Current Pharmaceutical Design 24 (April): 5528–36. doi:10.2174/1381612825666190306162658.